Drug information

Audio
Brand Name
Symtuza
Other Names
DRV/COBI/FTC/TAF, darunavir ethanolate/cobicistat/emtricitabine/tenofovir AF, darunavir ethanolate/cobicistat/emtricitabine/tenofovir alafenamide, darunavir/cobicistat/emtricitabine/tenofovir AF, darunavir/cobicistat/emtricitabine/tenofovir alafenamide fumarate
Drug Class
Combination Drugs
Protease Inhibitor (darunavir)
Nucleoside Reverse Transcriptase Inhibitor (emtricitabine, tenofovir alafenamide)
Pharmacokinetic Enhancer (cobicistat)
Drug Image(s): (Click to enlarge)
Chemical Image: (Click to enlarge)

darunavir ethanolate

Molecular Weight: 593.7377

cobicistat

Molecular Weight: 776.0347

emtricitabine

Molecular Weight: 247.249

tenofovir alafenamide fumarate

Molecular Weight: 1069.0138

FDA label informationFDA label information

Several FDA-approved drug labels may be available for darunavir / cobicistat / emtricitabine / tenofovir alafenamide. Clinical Info provides the following link to the DailyMed drug label solely as an example of the labels available for darunavir / cobicistat / emtricitabine / tenofovir alafenamide. Inclusion or absence of a drug label link on the Clinical Info site does not imply endorsement or lack thereof by Clinical Info. Search DailyMed or Drugs@FDA to access more information on darunavir / cobicistat / emtricitabine / tenofovir alafenamide, including additional drug labels and any generic equivalents.

Tablet